Santen Pharmaceutical Co

Italian pharmaceutical company, NTC, has entered into a commercial partnership with Santen Pharmaceutical — a pharma company focused on ophthalmology. Read more


In this article, Dr Frank Binder, VP of global supply chain management at Santen and keynote speaker at NEXUS '17 in Barcelona, discusses the challenges and opportunities that serialisation presents to mid-sized companies. Read more


Santen Pharmaceuticals has announced that the FDA has accepted the new drug application (NDA) for intravitreal (IVT) sirolimus for the treatment of non-infectious uveitis of the posterior segment (NIU-PS). Read more


Santen UK, the new subsidiary of the Japanese specialist ophthalmic pharma group, has joined The Association of the British Pharmaceutical Industry (ABPI). Read more


The completed transaction concerns products primarily intended for Asia, including Japan, South Korea and Europe excluding some countries Read more